Detalhe da pesquisa
1.
Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer.
Ann Oncol
; 35(7): 643-655, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38777726
2.
Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments.
Ann Oncol
; 34(6): 543-552, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921693
3.
Clinical development of therapies targeting TGFß: current knowledge and future perspectives.
Ann Oncol
; 31(10): 1336-1349, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32710930
4.
Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer.
Ann Oncol
; 31(10): 1366-1375, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32569727
5.
Circulating tumor DNA, and clinical features to guide rechallenge with BRAF inhibitors in BRAF-V600E mutated metastatic colorectal cancer.
Ann Oncol
; 35(2): 240-241, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37866812
6.
Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial.
Ann Oncol
; 30(5): 796-803, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30840064
7.
Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy.
Ann Oncol
; 30(3): 439-446, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30689692
8.
BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives.
Ann Oncol
; 28(11): 2648-2657, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045527
9.
Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer.
Ann Oncol
; 28(6): 1294-1301, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28368441
10.
Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer.
Br J Cancer
; 114(4): 372-80, 2016 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26766738
11.
Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial.
Ann Oncol
; 26(1): 132-140, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25319061
12.
Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer.
Ann Oncol
; 26(3): 535-41, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25515656
13.
Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemoradiotherapy before surgery in patients with locally advanced rectal cancer: is it ready for primetime?
Ann Oncol
; 29(3): 532-534, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29401228
14.
Sex and gender perspectives in colorectal cancer.
ESMO Open
; 8(2): 101204, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37018873
15.
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients.
Biomed Pharmacother
; 159: 114272, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706629
16.
Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer.
ESMO Open
; 8(3): 101198, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37119788
17.
Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer.
Clin Transl Oncol
; 24(6): 1209-1214, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34997474
18.
Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumors.
ESMO Open
; 7(5): 100576, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108560
19.
The impact of COVID-19 on oncology professionals-one year on: lessons learned from the ESMO Resilience Task Force survey series.
ESMO Open
; 7(1): 100374, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35007996
20.
Controversies in the treatment of RAS wild-type metastatic colorectal cancer.
Clin Transl Oncol
; 23(4): 827-839, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32789773